NanoTemper Technologies Brings Speed to Drug Discovery Screening, Launches Dianthus System

News provided by

NanoTemper Technologies

Jan 31, 2019, 10:24 ET

SOUTH SAN FRANCISCO, Calif., Jan. 31, 2019 /PRNewswire/ -- NanoTemper Technologies, maker of life science tools for protein characterization, launches its newest system, Dianthus, at the Society for Laboratory Automation and Screening (SLAS2019) conference in Washington, DC. Built to address the demands of drug discovery screening, Dianthus removes the complexity of binding interaction measurements and enables scientists to develop new drugs for every target faster and at lower costs.

Continue Reading
Get fast, non-stop, highly sensitive hit screening with Dianthus.
Get fast, non-stop, highly sensitive hit screening with Dianthus.
Get fast, non-stop, highly sensitive hit screening with Dianthus. Find hits for any target type in any buffer or bioliquid, measure the tightest interactions down to picomolar Kds, all by consuming the smallest amount of your target and library compounds. There's no fluidics which means no regular maintenance and no downtime. With Dianthus, get the fastest time to meaningful results with no immobilization required, because you demand it.
Get fast, non-stop, highly sensitive hit screening with Dianthus. Find hits for any target type in any buffer or bioliquid, measure the tightest interactions down to picomolar Kds, all by consuming the smallest amount of your target and library compounds. There's no fluidics which means no regular maintenance and no downtime. With Dianthus, get the fastest time to meaningful results with no immobilization required, because you demand it.

"There are two major challenges in drug discovery screening — the need to screen not only more molecules but more diverse ones covering a greater chemical space, and the need to address smaller projects with explorative targets," says Stefan Duhr, CEO of NanoTemper. "Dianthus has the flexibility to address both of these challenges."

Dianthus quickly identifies and ranks hits by quantifying molecular interactions in solution. It does this for any target type in any buffer or bioliquid and measures a wide range of interactions from millimolar down to picomolar Kds, all by consuming the smallest amount of your target and library compounds.

"Speed is a huge advantage and Dianthus is really fast, screening 10,000 compounds per day, which is unmatched in biophysical drug discovery," says Amit Gupta, Product Manager at NanoTemper. "That's only possible because it's very hands-off, with no fluidics so there's no cleaning or rinsing and virtually no downtime. It also uses industry-standard SBS microplates so it easily integrates into a variety of automation workflows."

Dianthus was inspired by our customer's feedback and was built because they demand fast, non-stop, highly sensitive hit screening. See why Dianthus is so important to drug discovery screening or visit nanotempertech.com/dianthus to find out more details. For the most up-to-date information, follow NanoTemper and #speedscreening on LinkedIn, Facebook and Twitter.

About NanoTemper Technologies
Our mission at NanoTemper Technologies is to enable everyone to do science that matters by always pushing the limits. We're focused on making biophysical tools accessible to anyone looking to characterize proteins in any industry. Working with customers striving to make a difference in the world gets us excited. If you're looking to measure binding affinity, protein stability or protein quality, let's talk.

Jocelyn Davé
VP of Marketing
NanoTemper Technologies
+1-415-316-6313 
[email protected]
nanotempertech.com

SOURCE NanoTemper Technologies

Related Links

https://nanotempertech.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED